Schedule 13G ownership disclosure

PTC Therapeutics Inc

Security class unavailable · CUSIP: 69366J200

Event date: 2018-05-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,326,140
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-031326
Form type
SC 13G
Filer
D. E. SHAW & CO, L.P.
CIK
CIK 1009268
Filed
May 29, 2018
Reporting period
May 16, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub